We are live on ! Find out more
TRHC

Tabula Rasa HealthCare, Inc. Common Stock

Delisted

TRHC was delisted on the 2nd of November, 2023.

67 hedge funds and large institutions have $80.2M invested in Tabula Rasa HealthCare, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 27 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% more capital invested

Capital invested by funds: $79.2M → $80.2M (+$1.05M)

16% less funds holding

Funds holding: 8067 (-13)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

62% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 21

63% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 27

Holders
67
Holders Change
-13
Holders Change %
-16.25%
% of All Funds
1.08%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
8
Increased
10
Reduced
27
Closed
21
Calls
$265K
Puts
Net Calls
+$265K
Net Calls Change
+$606K
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
26
Renaissance Technologies
New York
$349K -$477K -115,800 -62%
BCM
27
Bridgeway Capital Management
Texas
$248K -$103K -25,000 -33%
Northern Trust
28
Northern Trust
Illinois
$236K
Invesco
29
Invesco
Georgia
$234K -$989 -240 -0.5%
MCM
30
Mattern Capital Management
Colorado
$180K -$99 -24 -0.1%
Walleye Capital
31
Walleye Capital
New York
$147K -$407K -98,903 -77%
Morgan Stanley
32
Morgan Stanley
New York
$127K -$17.1K -4,161 -14%
TA
33
Teramo Advisors
Florida
$124K +$20.6K +5,000 +25%
Goldman Sachs
34
Goldman Sachs
New York
$121K +$27.2K +6,597 +37%
Tudor Investment Corp
35
Tudor Investment Corp
Connecticut
$93K
OC
36
Oppenheimer & Co
New York
$91.3K -$44.8K -10,862 -37%
SG Americas Securities
37
SG Americas Securities
New York
$84K
SSA
38
Schonfeld Strategic Advisors
New York
$73.8K -$50.7K -12,300 -45%
PP
39
PDT Partners
New York
$66.9K -$89.6K -21,751 -62%
William Blair & Company
40
William Blair & Company
Illinois
$66.8K -$7.66K -1,860 -12%
Charles Schwab
41
Charles Schwab
California
$58.1K
TSS
42
Two Sigma Securities
New York
$55.4K +$46.1K +11,194 New
Bank of New York Mellon
43
Bank of New York Mellon
New York
$54.9K -$6.7K -1,625 -13%
Deutsche Bank
44
Deutsche Bank
Germany
$51.9K
ACM
45
Argyle Capital Management
Pennsylvania
$50.6K
NSEDCP
46
NJ State Employees Deferred Compensation Plan
New Jersey
$49.5K
Russell Investments Group
47
Russell Investments Group
United Kingdom
$33.6K
Royal Bank of Canada
48
Royal Bank of Canada
Ontario, Canada
$30K -$80.7K -19,588 -76%
YC
49
Yarbrough Capital
Tennessee
$24.1K +$20.1K +4,874 New
TRCT
50
Tower Research Capital (TRC)
New York
$20K +$16.2K +3,926 +4,047%

TRHC Hedge Fund Activity: Q4 2022 in Review

67 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Tabula Rasa HealthCare, Inc. Common Stock (TRHC) for Q4 2022, worth a combined $80.2M — up 1.3% from $79.2M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of TRHC and 8 opened new positions — a net loss of 13 holders — while 27 trimmed existing stakes and 10 added.

The largest buyer was Kennedy Capital Management, opening a new position worth an estimated $4M. The largest seller was Repertoire Partners, cutting an estimated $2.92M.

  • 67 institutional investors held Tabula Rasa HealthCare, Inc. Common Stock (TRHC) as of Q4 2022, down from 80 in Q3 2022.
  • Funds reported $80.2M of Tabula Rasa HealthCare, Inc. Common Stock stock for Q4 2022, up 1.3% quarter-over-quarter.
  • 8 funds opened new Tabula Rasa HealthCare, Inc. Common Stock positions in Q4 2022 and 21 closed out, a net change of -13 holders.
  • The largest Tabula Rasa HealthCare, Inc. Common Stock buyer in Q4 2022 was Kennedy Capital Management, an estimated $4M added.
  • The largest Tabula Rasa HealthCare, Inc. Common Stock seller in Q4 2022 was Repertoire Partners, an estimated $2.92M sold.

Based on aggregated 13F filings for Q4 2022.